Heinz R. Reichmann
#121,836
Most Influential Person Now
Heinz R. Reichmann's AcademicInfluence.com Rankings
Heinz R. Reichmannmedical Degrees
Medical
#1875
World Rank
#2256
Historical Rank
Neurology
#176
World Rank
#246
Historical Rank
Heinz R. Reichmannphilosophy Degrees
Philosophy
#5549
World Rank
#8381
Historical Rank
Logic
#2806
World Rank
#3853
Historical Rank
Download Badge
Medical Philosophy
Why Is Heinz R. Reichmann Influential?
(Suggest an Edit or Addition)Heinz R. Reichmann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A randomized trial of deep-brain stimulation for Parkinson's disease. (2006) (2460)
- Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke (2009) (576)
- Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. (2015) (446)
- Electron transport chain defects in Alzheimer's disease. (1994) (439)
- Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors (2015) (433)
- Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. (1999) (410)
- Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice (2010) (409)
- Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography (1995) (403)
- Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. (2003) (385)
- Prevalence of smell loss in Parkinson's disease--a multicenter study. (2009) (344)
- Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice (2012) (334)
- Olfactory loss may be a first sign of idiopathic Parkinson's disease (2007) (322)
- Cognitive impairment in 873 patients with idiopathic Parkinson's disease (2008) (260)
- Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT (2004) (240)
- Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease (2010) (227)
- Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease (1994) (209)
- Non-motor dysfunction in Parkinson's disease. (2007) (207)
- Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. (2004) (204)
- Nonmotor fluctuations in Parkinson disease (2013) (203)
- EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease (2015) (202)
- Acute Cerebrovascular Disease in the Young: The Stroke in Young Fabry Patients Study (2013) (199)
- Depression and Parkinson’s disease (2004) (189)
- Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. (2007) (180)
- Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole. (2005) (167)
- Adherence to antiparkinson medication in a multicenter European study (2009) (167)
- Olfactory function in Parkinsonian syndromes (2002) (166)
- Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases (1995) (155)
- Different odor tests contribute differently to the evaluation of olfactory loss. (2008) (150)
- Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial (2011) (144)
- Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients (2002) (143)
- Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. (2007) (141)
- Cardiovascular autonomic dysfunction in Parkinson's disease (2010) (141)
- Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study (2020) (139)
- Biopsies of olfactory epithelium in patients with Parkinson's disease (2009) (138)
- Mitochondrial myopathy caused by long-term zidovudine therapy. (1990) (137)
- Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect (1990) (136)
- Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease (2006) (134)
- Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study (2005) (124)
- Biochemical and ultrastructural changes of skeletal muscle mitochondria after chronic electrical stimulation in rabbits (1985) (121)
- Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography (1997) (120)
- Primary Skin Fibroblasts as a Model of Parkinson's Disease (2012) (118)
- Olfactory Training in Patients with Parkinson's Disease (2013) (116)
- Clinical Criteria for the Diagnosis of Parkinson’s Disease (2010) (116)
- Exercise-induced fibre type transitions with regard to myosin, parvalbumin, and sarcoplasmic reticulum in muscles of the rat (1984) (109)
- Olfactory dysfunction as a diagnostic marker for Parkinson’s disease (2009) (108)
- Olfactory Loss in Parkinson's Disease (2011) (108)
- Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study (2009) (105)
- Modafinil for excessive daytime sleepiness in myotonic dystrophy (2001) (103)
- Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma (2010) (102)
- Loss of nocturnal blood pressure fall in various extrapyramidal syndromes (2009) (98)
- Medical and surgical management of advanced Parkinson's disease (2018) (98)
- Pathophysiology of the MELAS 3243 Transition Mutation* (1997) (97)
- Multiple symmetric lipomatosis (1994) (96)
- Genes associated with Parkinson syndrome (2008) (95)
- A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease (2008) (91)
- A comparative microphotometric study of succinate dehydrogenase activity levels in type I, IIA and IIB fibres of mammalian and human muscles (2004) (90)
- The Stem Cell Marker Prominin‐1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease (2008) (89)
- Olfactory Function in Parkinson's Disease (2010) (88)
- Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice (2009) (86)
- Mitochondrial DNA in migraine with aura (1996) (85)
- Role of iron in neurodegenerative diseases (2016) (84)
- Beyond tremor and rigidity: non-motor features of Parkinson’s disease (2009) (80)
- Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. (1996) (78)
- Does vagotomy reduce the risk of Parkinson's disease? (2015) (75)
- Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence (2015) (73)
- Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage. (2019) (73)
- Prediction of outcome in neurogenic oropharyngeal dysphagia within 72 hours of acute stroke. (2012) (72)
- Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS (2019) (72)
- α-Synuclein in Parkinson’s disease: causal or bystander? (2019) (71)
- Clinical neuroprotection in Parkinson's disease — Still waiting for the breakthrough (2010) (70)
- Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease. (2012) (69)
- VACTERL with the mitochondrial np 3243 point mutation. (1996) (69)
- Mitochondrial DNA mutations in multiple symmetric lipomatosis (1997) (68)
- Perspectives on recent advances in the understanding and treatment of Parkinson’s disease (2009) (67)
- View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication (2011) (66)
- Neurological multisystem manifestation in multiple symmetric lipomatosis: A clinical and electrophysiological study (1995) (66)
- Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy (1998) (65)
- Iron-dependent functions of mitochondria—relation to neurodegeneration (2011) (64)
- Olfactory function in patients with idiopathic Parkinson’s disease: effects of deep brain stimulation in the subthalamic nucleus (2005) (64)
- Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing‐off type fluctuations (2005) (64)
- Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial (2015) (64)
- Improved Odor Sensitivity in Attention-Deficit/Hyperactivity Disorder (2008) (63)
- Mutation analysis in myophosphorylase deficiency (McArdle's disease) (1998) (63)
- Pramipexole in Routine Clinical Practice (2003) (62)
- Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson's disease (2010) (62)
- Incidence of Parkinson’s disease in a large patient cohort with idiopathic smell and taste loss (2018) (61)
- CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function (2010) (60)
- Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis (2009) (60)
- Differentiation of parkinsonian syndromes according to differences in executive functions (2003) (60)
- Reliability of brain CT evaluation by stroke neurologists in telemedicine (2013) (60)
- Transdermal rotigotine for the perioperative management of Parkinson’s disease (2010) (59)
- Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease. (2007) (58)
- Non-motor features of Parkinson's disease: depression and dementia. (2009) (57)
- Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept (2010) (57)
- Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves (2018) (57)
- Fibre type specific transformations in the enzyme activity pattern of rat vastus lateralis muscle by prolonged endurance training (1983) (57)
- Clinical prodromes of neurodegeneration in Anderson-Fabry disease (2015) (56)
- "Atraumatic" Sprotte needle reduces the incidence of post-lumbar puncture headaches. (2002) (55)
- Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis (2020) (53)
- Olfactory fMRI in Patients with Parkinson's Disease (2010) (53)
- New Insights into the Metabolic Consequences of Large‐Scale mtDNA Deletions: A Quantitative Analysis of Biochemical, Morphological, and Genetic Findings in Human Skeletal Muscle (2000) (53)
- Brief communication: Becker muscular dystrophy: Detection of unusual disease courses by combined approach to dystrophin analysis (1992) (52)
- Treatment of Parkinson’s disease in the advanced stage (2013) (52)
- Oxidative Stress to Dopaminergic Neurons as Models of Parkinson's Disease (2004) (52)
- Static posturography in aging and Parkinson's disease (2012) (52)
- A method for quantitative extraction of enzymes and metabolites from tissue samples in the milligram range. (1982) (52)
- Clinical spectrum of the MELAS mutation in a large pedigree (1995) (51)
- Mitochondrial dysfunction with myoclonus epilepsy and ragged‐red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple isymmetric lipomatosis (1997) (51)
- Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene. (1994) (51)
- Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS) (2015) (50)
- Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader‐blinded monocenter echocardiography study (2007) (50)
- Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy (2011) (50)
- Mitochondrial DNA in Postmortem Brain from Patients with Parkinson's Disease (1991) (50)
- Lewy body dementia and Parkinson’s disease with dementia (2008) (49)
- Kinetic tremor in Parkinson’s disease – an underrated symptom (2006) (49)
- Mitochondrial gene mutations and diabetes mellitus (1993) (48)
- Analysis of HLA class I and II alleles in sporadic inclusion-body myositis (2003) (48)
- Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease (2010) (48)
- Variable penetrance of a familial progressive necrotising encephalopathy due to a novel tRNAIle homoplasmic mutation in the mitochondrial genome (2004) (47)
- The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. (1995) (47)
- Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma. (2010) (47)
- Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes (2008) (46)
- Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial (2010) (46)
- Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology (2014) (45)
- Mitochondrial myopathy due to complex III deficiency with normal reducible cytochrome b concentration. (1986) (45)
- Microcurrent transcutaneous electric nerve stimulation in painful diabetic neuropathy: a randomized placebo-controlled study. (2011) (45)
- A mild juvenile variant of type IV glycogenosis (1992) (45)
- A clinical approach towards smell loss in Parkinson's disease. (2014) (44)
- Sleep disorders in Parkinson's disease. (2014) (44)
- Ipsi- and contralateral fibre transformations by cross-reinnervation. A principle of symmetry (1983) (44)
- Comprehensive autonomic assessment does not differentiate between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy (2009) (44)
- Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate. (1994) (44)
- Mitochondrial dysfunction – a pathogenetic factor in Parkinson’s disease (2000) (43)
- Acute endovascular treatment delivery to ischemic stroke patients transferred within a telestroke network: a retrospective observational study (2017) (43)
- The nonmotor features of Parkinson's disease: pathophysiology and management advances. (2016) (43)
- Parkinson’s Disease and Related Disorders (2006) (43)
- Olfactory impairment in Parkinson’s disease is a consequence of central nervous system decline (2017) (43)
- Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation (2004) (42)
- Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo31P-MRS in a patient with mitochondrial cytopathy (1995) (42)
- Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes (2010) (41)
- Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction (2006) (41)
- Enzymes of Fatty Acid β‐Oxidation in Developing Brain (1988) (41)
- Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential (2003) (41)
- Metabolic patterns in malignant gliomas (2005) (41)
- New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies (2016) (41)
- Neuralgic amyotrophy following infection with SARS‐CoV‐2 (2020) (40)
- 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I. (1995) (40)
- Correlation of Quantitative Motor State Assessment Using a Kinetograph and Patient Diaries in Advanced PD: Data from an Observational Study (2016) (40)
- Valsalva manoeuvre in patients with different Parkinsonian disorders (2009) (40)
- Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes (2009) (40)
- HLA Typing and Parkinson’s Disease (2003) (39)
- Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions (2001) (39)
- Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis (2011) (39)
- Sleep and non-motor symptoms in Parkinson’s disease (2013) (39)
- A comparison of two ATPase based schemes for histochemical muscle fibre typing in various mammals (2004) (39)
- Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta‐analysis of levodopa‐controlled trials (2014) (39)
- The Gut and Nonmotor Symptoms in Parkinson's Disease. (2017) (38)
- Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresis. (2009) (38)
- Novel mitochondrial DNA mutations in Parkinson's disease (2002) (38)
- [Attitudes towards patient care at the end of life. A survey of directors of neurological departments]. (2004) (38)
- Bromal-derived tetrahydro-beta-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration. (2000) (37)
- Enzyme activity measured in single muscle fibers in partial cytochrome c oxidase deficiency (1988) (37)
- Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases (1998) (37)
- Parkinson’s disease as a multisystem disorder (2017) (36)
- Contrast-enhanced transcranial color-coded duplexsonography in stroke patients with limited bone windows. (2000) (36)
- Atraumatic needle reduces the incidence of post-lumbar puncture syndrome (1994) (36)
- Autonomic dysfunction in different subtypes of multiple system atrophy (2008) (36)
- Night‐time sleep in Parkinson's disease – the potential use of Parkinson's KinetiGraph: a prospective comparative study (2016) (36)
- Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link? (2001) (35)
- Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q. (1996) (34)
- Neurotoxic mechanisms of 2,9‐dimethyl‐β‐carbolinium ion in primary dopaminergic culture (2006) (34)
- 9-Methyl-β-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture (2008) (34)
- Switching and combining of dopamine agonists (2004) (34)
- Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug? (2011) (34)
- Focal myositis of the temporal muscle (1993) (34)
- Effects of chronic stimulation on the metabolic heterogeneity of the fibre population in rabbit tibialis anterior muscle. (1984) (34)
- Premotor Diagnosis of Parkinson’s Disease (2017) (34)
- A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population (2002) (33)
- Computed tomographically‐controlled injection of botulinum toxin into the longus colli muscle in severe anterocollis (2004) (33)
- Pergolide protects dopaminergic neurons in primary culture under stress conditions (2002) (32)
- Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis (1999) (32)
- Inter- and intraspecies comparisons of fibre type distribution and of succinate dehydrogenase activity in type I, IIA and IIB fibres of mammalian diaphragms (2004) (32)
- Accumulation and therapeutic modulation of 6-sulfo LacNAc+ dendritic cells in multiple sclerosis (2014) (32)
- Emergency Transfer of Acute Stroke Patients within the East Saxony Telemedicine Stroke Network: A Descriptive Analysis (2014) (32)
- Cerebral Vasculitis with Multiple Infarcts Caused by Lyme Disease (2003) (32)
- Autonomic dysfunction in patients with progressive supranuclear palsy (2008) (32)
- Chocolate consumption is increased in Parkinson’s disease (2009) (31)
- Early sleep apnea screening on a stroke unit is feasible in patients with acute cerebral ischemia (2013) (31)
- Rotigotine transdermal system for perioperative administration (2007) (31)
- Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture. (2014) (31)
- Modern treatment in Parkinson’s disease, a personal approach (2015) (30)
- Treatment strategies in early and advanced Parkinson disease. (2015) (30)
- Depression and care-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients. (2012) (29)
- Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. (2016) (29)
- Parkinson’s disease between internal medicine and neurology (2015) (29)
- Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type (1998) (28)
- The exceptional properties of 9‐methyl‐β‐carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti‐inflammatory effects (2010) (28)
- Investigation on the mitochondrial transfer RNALeu(UUR) in blood cells from patients with cluster headache (1996) (28)
- Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. (1994) (28)
- Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes (2007) (28)
- Dementia in idiopathic Parkinson’s syndrome (2004) (28)
- Motor Impairment Estimates via Touchscreen Typing Dynamics Toward Parkinson's Disease Detection From Data Harvested In-the-Wild (2018) (28)
- Protection of dopaminergic neurons in primary culture by lisuride (2002) (28)
- Restless legs syndrome. (2016) (28)
- Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency. (1994) (28)
- TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain. (1995) (27)
- The impact of Parkinson’s disease and subthalamic deep brain stimulation on reward processing (2015) (26)
- Levodopa therapy in Parkinson’s disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine (2014) (26)
- Efficacy and tolerability of rasagiline in daily clinical use – a post‐marketing observational study in patients with Parkinson’s disease (2010) (26)
- Long-term treatment with dopamine agonists in idiopathic in Parkinson's disease (2000) (26)
- Effects of low frequency electriclal stimulation on enzyme and isozyme patterns of dystrophic mouse muscle (1981) (26)
- Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease (2011) (25)
- Ergoline and non-ergoline derivatives in the treatment of Parkinson’s disease (2006) (25)
- Effect of highly halogenated β‐carbolines on dopaminergic cells in culture and on mitochondrial respiration (1999) (25)
- Association of sleep apnea with clinically silent microvascular brain tissue changes in acute cerebral ischemia (2013) (25)
- Distal muscular dystrophy of Miyoshi type (1996) (25)
- Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats. (1995) (25)
- [The Charcot joint]. (1999) (25)
- Treatment of dysautonomia in extrapyramidal disorders (2011) (25)
- Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin (1996) (25)
- Transdermal delivery of dopamine receptor agonists. (2009) (24)
- Intrathecal methylprednisolone for postherpetic neuralgia. (2001) (24)
- Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients (1998) (24)
- Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with 18F-dopa brain PET in normal controls and patients with Parkinson’s disease (2011) (24)
- Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double‐blind, baseline‐controlled trial (2018) (24)
- Familial mixed congenital myopathy with rigid spine phenotype (1997) (24)
- Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes (2007) (24)
- Neurotoxic effects on the dopaminergic system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline), a potential mammalian alkaloid : in vivo and in vitro studies (1996) (24)
- Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications (2016) (24)
- Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson’s disease: focus on levodopa/carbidopa/entacapone (2012) (23)
- Perfusion computed tomography in posterior circulation stroke: predictors and prognostic implications of focal hypoperfusion (2018) (23)
- Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders (2006) (23)
- Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage (“Neuroprotection”) (2015) (23)
- Processing of Artificial Peptide-DNA-Conjugates by the Mitochondrial Intermediate Peptidase (MIP) (1999) (22)
- Oculopharyngeal muscular dystrophy in a northern German family linked to chromosome 14q, and presenting carnitine deficiency (1997) (22)
- Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease (2013) (22)
- High-dose therapy with ropinirole in patients with Parkinson's disease (2001) (22)
- Quantifying antiepileptic drug effects using intrinsic excitability measures (2016) (22)
- Trigonometric Regressive Spectral Analysis Reliably Maps Dynamic Changes in Baroreflex Sensitivity and Autonomic Tone: The Effect of Gender and Age (2010) (22)
- Effects of rasagiline on olfactory function in patients with Parkinson's disease (2013) (22)
- Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease (1993) (22)
- Recognition and treatment of autonomic disturbances in Parkinson’s disease (2015) (21)
- Follow-Up in Carriers of the ‘MELAS’ Mutation without Strokes (1998) (21)
- Decannulation and Functional Outcome After Tracheostomy in Patients with Severe Stroke (DECAST): A Prospective Observational Study (2017) (21)
- Autonomic function and cerebral autoregulation in patients undergoing carotid endarterectomy. (2010) (21)
- Determination of Baroreflex Sensitivity during the Modified Oxford Maneuver by Trigonometric Regressive Spectral Analysis (2011) (21)
- A spectrophotometric method for the determination of free and esterified carnitine. (1989) (20)
- Mitochondrial abnormalities in the myofibrillar myopathies (2015) (20)
- Enzyme activities of fatty acid oxidation and the respiratory chain in chronically stimulated fast-twitch muscle of the rabbit (1991) (20)
- Transient neonatal Lambert-Eaton syndrome (2008) (20)
- Apolipoprotein E and Alpha-1-Antichymotrypsin Polymorphisms in Sporadic Inclusion Body Myositis (2004) (20)
- Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson’s disease (2006) (20)
- Ragged red or ragged blue fibers. (1996) (20)
- Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease (2016) (19)
- Decreased parvalbumin contents in skeletal muscles of C57BL/6J(dy2J/dy2J) dystrophic mice (1985) (19)
- Selective hyposmia in Parkinson’s disease? (2013) (19)
- Noninvasive Assessment of the Circle of Willis in Cerebral Ischemia: The Potential of CT Angiography and Contrast-Enhanced Transcranial Color-Coded Duplexsonography (1999) (19)
- The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil. (2006) (19)
- Changing dopamine agonist treatment in Parkinson's disease: experiences with switching to pramipexole. (2006) (19)
- Education Research: Cognitive performance is preserved in sleep-deprived neurology residents (2009) (19)
- Levodopa in the treatment of Parkinson's disease: Current controversies (2005) (19)
- Cranial MRI and CT in patients with left atrial myxoma (2004) (19)
- Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease. (2003) (19)
- The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke. (2015) (19)
- Neuropsychological status of mitochondrial encephalomyopathies (1995) (19)
- Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat (1995) (18)
- [Multiple sclerosis management system 3D. Moving from documentation towards management of patients]. (2012) (18)
- Different diagnostic criteria for Parkinson disease: what are the pitfalls? (2013) (18)
- Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience (2021) (18)
- Parkinson's disease and the electron transport chain in postmortem brain. (1993) (18)
- Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases. (1996) (18)
- Cytochrome C oxidase deficiency and Long‐Chain acyl coenzyme A dehydrogenase deficiency with Leigh's subacute necrotizing encephalomyelopathy (1992) (18)
- Assessment of real life eating difficulties in Parkinson’s disease patients by measuring plate to mouth movement elongation with inertial sensors (2021) (18)
- Accelerated Age-Dependent Hippocampal Volume Loss in Parkinson Disease With Mild Cognitive Impairment (2017) (18)
- Clycerolphosphate oxidase and succinate dehydrogenase activities in IIA and IIB fibres of mouse and rabbit tibialis anterior muscles (2004) (18)
- Echo-Enhanced Transcranial Color-Coded Duplexsonography to Study Collateral Blood Flow in Patients with Symptomatic Obstructions of the Internal Carotid Artery and Limited Acoustic Bone Windows (2001) (18)
- A rapid and sensitive PCR screening method for point mutations associated with mitochondrial encephalomyopathies. (1994) (17)
- Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. (2019) (17)
- Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing via deep learning (2020) (17)
- Potassium channel blocker 4‐aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2 — A video case report (2008) (17)
- The corpus callosum in communicating and noncommunicating hydrocephalus (1995) (17)
- Switching and combining dopamine agonists (2003) (17)
- Histological, enzymatic and mitochondrial DNA studies in patients with Kearns-Sayre syndrome and chronic progressive external ophthalmoplegia. (1991) (17)
- Association of history of cerebrovascular disease with severity of COVID-19 (2020) (17)
- Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect. (1993) (17)
- Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage (2019) (17)
- Early Parkinson’s disease patients on rasagiline present with better odor discrimination (2015) (17)
- Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol (2016) (16)
- Cardiac and autonomic function in patients with Wilson’s disease (2019) (16)
- Enzymes of fatty acid beta-oxidation in developing brain. (1988) (16)
- Neural degeneration in Parkinson's disease. (2001) (16)
- Enzyme activities and activity profiles in muscle fibers of dystrophic, immature‐normal, and adult‐normal BL6 mice (1984) (16)
- Highly Halogenated Tetrahydro-β-Carbolines as a New Class of Dopaminergic Neurotoxins (1998) (16)
- Validation of a self‐completed Dystonia Non‐Motor Symptoms Questionnaire (2019) (16)
- Relationships between early alterations in parvalbumins, sarcoplasmic reticulum and metabolic enzymes in chronically stimulated fast twitch muscle (1983) (16)
- Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study (2013) (15)
- Practical importance of neuroprotection in Parkinson's disease (2002) (15)
- Fabry Disease With Concomitant Lewy Body Disease (2019) (15)
- Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. (2018) (15)
- Reduced Body Mass Index in Parkinson’s Disease: Contribution of Comorbid Depression (2013) (15)
- No benefits of hypothermia in patients treated with hemicraniectomy for large ischemic stroke (2017) (15)
- Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson’s Disease (CAPTURE PD): Protocol for a Multicenter Study (2017) (15)
- A rapid fluorometric method for the determination of carnitine palmitoyltransferase. (1993) (15)
- Validation of Multiparametric Ultrasonography Criteria with Digital Subtraction Angiography in Carotid Artery Disease: A Prospective Multicenter Study (2018) (15)
- Mitochondrial changes in muscle phosphoglycerate kinase deficiency. (1996) (15)
- Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study (2020) (15)
- Early Versus Delayed Initiation of Pharmacotherapy in Parkinson’s Disease (2014) (15)
- Quality of life in Parkinson's disease - patient, clinical and research perspectives (2014) (14)
- Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease (2000) (14)
- Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients. (1997) (14)
- Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia (1994) (14)
- Cardiovascular autonomic testing in extrapyramidal disorders (2011) (14)
- Review: Treatment of dysautonomia in extrapyramidal disorders (2010) (14)
- Spatial learning deficits in Parkinson's disease with and without mild cognitive impairment. (2017) (13)
- Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report (2011) (13)
- Mitochondrial Cytopathies (2003) (13)
- Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease* (2011) (13)
- Endovascular therapy for anterior circulation large vessel occlusion in telestroke (2019) (13)
- Extracorporeal apheresis therapy for Alzheimer disease—targeting lipids, stress, and inflammation (2019) (13)
- Iron-dependent enzymes in Parkinson's disease. (1995) (13)
- [Adherence to neurologic treatment. Lessons from multiple sclerosis]. (2008) (13)
- Hypoglycemia‐induced choreoathetosis associated with hyperintense basal ganglia lesions in T1‐weighted brain MRI (2010) (12)
- Autonomic Dysfunction in Wilson's Disease: A Comprehensive Evaluation during a 3-Year Follow Up (2017) (12)
- Cardiac Manifestation of Wilson's Disease. (2018) (12)
- A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease (2015) (12)
- Pilomotor function is impaired in patients with Parkinson's disease: A study of the adrenergic axon-reflex response and autonomic functions. (2016) (12)
- A 35-year-old bricklayer with hemimyoclonic jerks (1998) (12)
- Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome (2003) (12)
- Assessment of cutaneous axon-reflex responses to evaluate functional integrity of autonomic small nerve fibers (2020) (12)
- Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study (2020) (12)
- Accurate Detection of Parkinson's Disease in Tremor Syndromes Using Olfactory Testing (2014) (12)
- Carnitine analysis in normal human red blood cells, plasma, and muscle tissue. (1994) (11)
- [Pramipexole in Parkinson disease. Results of a treatment observation]. (2002) (11)
- “An essay on the shaking palsy” 200 years old (2017) (11)
- Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture. (2014) (11)
- Differential response of enzyme activities in rat diaphragm and intercostal muscles to exercise training (1988) (11)
- Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson’s disease treated with L-DOPA (2017) (11)
- Gasoline vapors induce severe rhabdomyolysis (1994) (11)
- Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance (2015) (10)
- Metabolic Patterns in Meningiomas (2003) (10)
- Mypopathy in Williams-Beuren syndrome (1991) (10)
- Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease (2018) (10)
- Multi-parametric ultrasound criteria for internal carotid artery disease—comparison with CT angiography (2016) (10)
- Mitochondrial dysfunction in adult-onset myopathies with structural abnormalities (2004) (10)
- [Dysphagia diagnostics and therapy of acute stroke: federal survey of certified stroke units]. (2012) (10)
- The cytochemical determination of enzyme activities in single skeletal-muscle fibres from patients with a partial deficiency of cytochrome oxidase (1985) (10)
- Substantia nigra fractional anisotropy changes confirm the PD at-risk status of patients with idiopathic smell loss. (2018) (10)
- The cold hand sign in multiple system atrophy: skin perfusion revisited (2010) (10)
- [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. (2008) (10)
- Parkinson’s disease and translational research (2020) (10)
- Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release (2011) (10)
- Beta‐oxidation enzymes in normal human muscle and in muscle from a patient with an unusual form of myopathic carnitine deficiency (1985) (10)
- Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time (2012) (10)
- Active and healthy ageing for Parkinson's disease patients' support: A user's perspective within the i-PROGNOSIS framework (2016) (10)
- Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study (2006) (10)
- Biochemical studies in mitochondrial encephalomyopathy. (1987) (10)
- Early Parkinson’s Disease Detection via Touchscreen Typing Analysis using Convolutional Neural Networks (2019) (10)
- LDL apheresis improves deranged cardiovagal modulation in hypercholesterolemic patients. (2010) (10)
- Multiple-Sklerose-Dokumentationssystem 3D (2011) (10)
- Glucocorticoid-sensitive hereditary inclusion body myositis (1996) (10)
- Budipine in Parkinson's tremor (2006) (10)
- Parkinson’s Disease Detection Based on Running Speech Data From Phone Calls (2021) (10)
- The Stem Cell Marker Prominin-1/CD133 On Membrane Particles In Human Cerebrospinal Fluid Offers Novel Approaches For Studying CNS Disease (2007) (9)
- Neuroprotection in idiopathic Parkinson's disease (2002) (9)
- Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic (2020) (9)
- [Organized Post-Stroke Care through Case Management on the Basis of a Standardized Treatment Pathway : Results of a Single-Centre Pilot Study]. (2016) (9)
- MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation (2021) (9)
- Mitochondrial dysfunction in Parkinson's disease--revisited. (2007) (9)
- Myopathy in Williams-Beuren syndrome. (1991) (9)
- Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: An exploratory study (2020) (9)
- Comparison of chocolate to cacao-free white chocolate in Parkinson’s disease: a single-dose, investigator-blinded, placebo-controlled, crossover trial (2012) (9)
- MITOCHONDRIA–RELATED ENCEPHALOMYOPATHIES (1989) (9)
- Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma (2020) (9)
- Cost-of-illness in multiple system atrophy and progressive supranuclear palsy (2011) (9)
- Whole blood genome-wide expression profiling and network analysis suggest MELAS master regulators (2011) (9)
- Early Tracheostomy Is Associated With Shorter Ventilation Time and Duration of ICU Stay in Patients With Myasthenic Crisis—A Multicenter Analysis (2020) (9)
- Microphotometric determination of enzyme activities in type-grouped fibres of reinnervated rat muscle (2004) (8)
- Clinical Diagnosis and Management of Dystonia (2008) (8)
- [Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis]. (2008) (8)
- Dementia – The real problem for patients with Parkinson's disease (2014) (8)
- Telemedical Brain Computed Tomography Misinterpretation by Stroke Neurologists Is Not Associated with Thrombolysis-Related Intracranial Hemorrhage. (2015) (8)
- Enzyme activities, histochemistry and myosin light chain pattern in extraocular muscles of rabbit (2004) (8)
- Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study. (2014) (8)
- Thunderclap headache durch Kleinhirninfarkt (2008) (8)
- Innovative Parkinson's Disease Patients' Motor Skills Assessment: The i-PROGNOSIS Paradigm (2020) (8)
- Multiple brain abscesses in an immunocompetent patient after undergoing professional tooth cleaning. (2014) (8)
- Fatty Acid Mitochondrial Disorders (2010) (8)
- Should Skin Biopsies Be Performed in Patients Suspected of Having Parkinson's Disease? (2017) (8)
- Emetine-induced myopathy and carnitine deficiency (1990) (8)
- Schnitzler’s syndrome with neurological findings (2003) (8)
- Assistive HCI-Serious Games Co-design Insights: The Case Study of i-PROGNOSIS Personalized Game Suite for Parkinson’s Disease (2021) (8)
- Regional distribution and characterization of nitric oxide synthase activity in the brain of the common marmoset. (1995) (8)
- Progressive fatal pancytopenia, psychomotor retardation and muscle carnitine deficiency in a child with ethylmalonic aciduria and ethylmalonic acidaemia (1990) (8)
- [Impulsive-compulsive behaviours in a German Parkinson's disease outpatient sample]. (2013) (8)
- Mitochondrial disorders in degenerative ataxias (1996) (8)
- Lower Energy Intake among Advanced vs. Early Parkinson’s Disease Patients and Healthy Controls in a Clinical Lunch Setting: A Cross-Sectional Study (2020) (8)
- Influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, lipoic acid and L-deprenyl on the interplay between cellular redox systems. (1994) (8)
- Muscle pathology correlates with permanent weakness in hypokalemic periodic paralysis: a case report (2004) (7)
- Reversal of the neurological deficit in acute stroke with the signal of efficacy trial of auto-BPAP to limit damage from suspected sleep apnea (Reverse-STEAL): study protocol for a randomized controlled trial (2013) (7)
- Regional distribution and characterization of nitric oxide synthase activity in the brain of the common marmoset (1995) (7)
- Synergistic effect of α-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture (2006) (7)
- [Treatment of autonomic dysfunction in patients with extrapyramidal disorders]. (2010) (7)
- Multisystem triglyceride storage disorder without ichthyosis in two siblings (1994) (7)
- Sleep Disturbances and Sleep Disordered Breathing Impair Cognitive Performance in Parkinson’s Disease (2020) (7)
- Alterations in phenotype expression of muscle by chronic nerve stimulation. (1985) (7)
- Progression of myopathology in Kearns-Sayre syndrome: a morphological follow-up study (2004) (7)
- Perfusion of the psoas muscle of the rabbit. Metabolism of a homogeneous muscle composed of "fast glycolytic" fibres. (1986) (7)
- Sarcoid myopathy and mitochondrial respiratory chain defects: clinicopathological, biochemical and molecular biological analyses (1995) (7)
- [Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany]. (2011) (7)
- Regular lipoprotein apheresis maintains residual cardiovascular and microvascular function in patients with advanced atherosclerotic disease. (2013) (7)
- Feasibility of a Multimodal Telemedical Intervention for Patients with Parkinson’s Disease—A Pilot Study (2022) (7)
- Neurodegeneration-associated proteins and inflammation in sporadic inclusion-body myositis. (2001) (7)
- Neurological long-term follow-up in left atrial myxoma: Are late complications frequent or rare? (1992) (7)
- Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations. (2019) (7)
- Association of Anesthetic Exposure Time With Clinical Outcomes After Endovascular Therapy for Acute Ischemic Stroke (2019) (7)
- Prion codon 129 homozygosity and sporadic inclusion body myositis (2001) (7)
- Hemiplegic migraine with reversible cerebral vasoconstriction caused by ATP1A2 mutations (2013) (7)
- Metabolic and Non-Metabolic Peripheral Neuropathy: Is there a Place for Therapeutic Apheresis? (2019) (7)
- [Thunderclap headache caused by cerebellar infarction]. (2008) (6)
- Progression of Parkinson’s Disease and Unmet Needs in Mid- to Late-stage Patients (2015) (6)
- Dementia with Lewy bodies (2006) (6)
- Myopathies and cardiomyopathies: histochemical and biochemical analyses. (1991) (6)
- Misjudgment of pre-stroke functional status contradicts beneficial outcomes after endovascular therapy for large vessel occlusion (2019) (6)
- Smartwatch-based Activity Analysis During Sleep for Early Parkinson’s Disease Detection (2020) (6)
- A critical review of evidence for preclinical differences between rasagiline and selegiline (2012) (6)
- Changes of energy metabolism, myosin light chain composition, lactate dehydrogenase isozyme pattern and fibre type distribution of denervated fast-twitch muscle from rabbit after low frequency stimulation (1985) (6)
- Rasagilin im klinischen Alltag (2008) (6)
- Enzyme activity analyses along ragged-red and normal single muscle fibres (1992) (6)
- Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients (2004) (6)
- Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture. (2016) (6)
- Coordinate enzymatic activity of beta-oxidation and purine nucleotide cycle in a diversity of muscle and other organs of rat. (1991) (6)
- Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy – Final report (2006) (6)
- Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson’s disease (2019) (6)
- [Proximal weakness and exercise-induced pain as initial symptom of oculopharyngeal muscular dystrophy]. (2001) (5)
- Validity of the DESPAR questionnaire as a new screening tool for depression in Parkinson’s disease (2011) (5)
- Influence of direct low frequency stimulation on contractile properties of denervated fast-twitch rabbit muscle (1985) (5)
- Treatment strategies for nonmotor manifestations of Parkinson's disease (2009) (5)
- Progressive Neurodegeneration of the Dopaminergic system and Inhibition of the Complex I Induced by the Chloral-Derived Tetrahydro-β-Carboline TaClo (1996) (5)
- Subcutaneous microdialysis in mitochondrial cytopathy (2001) (5)
- Asymmetry of Periodic Leg Movements in Sleep (PLMS) in Parkinson's Disease. (2019) (5)
- Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study (1990) (5)
- Treatment strategies for nonmotor manifestations of Parkinson's disease. (2009) (5)
- Electrostimulation-induced changes in the enzyme activity pattern of dystrophic mouse muscles. (1983) (5)
- The stroke east Saxony pilot project for organized post‐stroke care: a case–control study (2016) (5)
- Practically applicable nerve ultrasound models for the diagnosis of axonal and demyelinating hereditary motor and sensory neuropathies (HMSN) (2017) (5)
- [Standardized bicycle ergometry test in mitochondrial myopathies. Indications, interferences and clinical parameters]. (1998) (5)
- Quantitative enzyme histochemistry in muscle fibres. (1989) (5)
- Using IMU Sensors to Assess Motor Degradation of PD Patients by Modeling In-meal Plate-to-Mouth Movement Elongation (2020) (5)
- Primary T-cell lymphoma of the cerebellum (1996) (5)
- Leber´s hereditary optic neuroretinopathy (1993) (5)
- [Parainfectious polyneuropathy and miller-fisher-syndrome in combination with anemia in Mycoplasma pneumoniae infection]. (2008) (5)
- Improving the assessment of everyday cognitive functioning in patients with epilepsy by means of proxy reports (2015) (5)
- Acute kidney injury in patients with malignant middle cerebral artery infarction undergoing hyperosmolar therapy with mannitol. (2021) (5)
- Corrigendum to “Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease” [Parkinsonism Relat Disord (2012) 994–997] (2013) (5)
- One nerve suffices: A clinically guided nerve ultrasound protocol for the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis (ALS) (2020) (5)
- [Axon-reflex based nerve fiber function assessment in the detection of autonomic neuropathy]. (2014) (5)
- Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson's Disease (2021) (5)
- CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy (2021) (5)
- On the stability of key enzymes of energy metabolism in muscle biopsies. (1990) (5)
- Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia (2020) (5)
- The principle of determining relative enzyme activities by comparative kinetic microphotometryin situ (1989) (4)
- Painful Myopathies–Metabolism of Muscle Cells and Metabolic Myopathies (2004) (4)
- Randomized controlled three-arm study of NADA acupuncture for alcohol addiction. (2020) (4)
- Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. (2015) (4)
- Variability of symptoms in neuralgic amyotrophy following infection with SARS‐CoV‐2 (2020) (4)
- [The Geriatric Patient with Parkinson's Disease - a Neurological Challenge]. (2016) (4)
- American Society for Stereotactic and Functional Neurosurgery Bestows Distinguished Service Award on Dr. med. h.c. mult. Thomas Karger and Prof. Dr. Phil Gildenberg (2003) (4)
- Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window (2021) (4)
- Adult onset lipid storage in gastric mucosa and skeletal muscle fibers associated with gastric pain, progressive muscle weakness and partial deficiency of cytochrome C oxidase. (1991) (4)
- Randomized Sham-Controlled Pilot Study of Neurocardiac Function in Patients With Acute Ischaemic Stroke Undergoing Heart Rate Variability Biofeedback (2021) (4)
- Side-Dependent Ion Effects on the Rate of Ouabain Binding to Reconstituted Human Red Cell Ghosts (1983) (4)
- Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy (2017) (4)
- Erratum: Processing of artificial peptide-DNA-conjugates by the mitochondrial intermediate peptidase (MIP) (Biol. Chem. (1999) vol 380 (961-967)) (2000) (4)
- Dopamine Agonist Therapy in Advanced Parkinson’s Disease (2009) (4)
- 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes (2020) (4)
- Initiation of Parkinson’s disease treatment (2008) (4)
- Low Diagnostic Yield of Routine Cerebrospinal Fluid Analysis in Juvenile Stroke (2018) (4)
- The Medical Faculties in Danger (2006) (4)
- Effects of safinamide on pain in patients with fluctuating Parkinson's disease (2021) (4)
- Restless legs syndrome - the under-recognised non-motor burden: a questionnaire-based cohort study (2019) (4)
- Putaminal Dopamine Turnover in de novo Parkinson's Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes. (2019) (4)
- Decompressive Hemicraniectomy in Elderly Patients With Space-Occupying Infarction (DECAP): A Prospective Observational Study (2019) (4)
- Parcellation of the Subthalamic Nucleus in Parkinson’s Disease: A Retrospective Analysis of Atlas- and Diffusion-Based Methods (2020) (4)
- Association of Hypertensive Intracerebral Hemorrhage with Left Ventricular Hypertrophy on Transthoracic Echocardiography (2020) (4)
- Thinking beyond borders. Infective myocarditis on top of MELAS-cardiomyopathy first case description. (2016) (4)
- Laboratory assessments in the course of Parkinson’s disease: a clinician’s perspective (2015) (4)
- Association of mitochondrial disorders with lymphoid malignancies. (2007) (4)
- Neuropsychiatric Symptoms of Movement Disorders (2015) (3)
- SINGLE FIBER RESPONSE TO A HEAVY TRAINING PROTOCOL IN RAT VASTUS LATERALIS MUSCLE (1984) (3)
- [Bilateral symmetrical reversible thalamic lesion within the scope of encephalitis]. (1987) (3)
- [Therapy of metabolic myopathies]. (1993) (3)
- [The prevalence of Parkinson's disease, associated dementia, and depression in Dresden]. (2013) (3)
- Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report (2020) (3)
- The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration (1990) (3)
- Cerebral Venous Drainage in Patients With Space-Occupying Middle Cerebral Artery Infarction: Effects on Functional Outcome After Hemicraniectomy (2018) (3)
- Dopamine and Glutamate in Parkinson’s Disease (2005) (3)
- [Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom]. (2018) (3)
- Chronic progressive external ophthalmoplegia with a novel mitochondrial DNA deletion and a mutation in the tRNALEU(UUR) gene (1999) (3)
- [Gene expression profiling of classic mitochondrial disorders. Its value in finding therapeutic strategies]. (2007) (3)
- Neurotrophic effects of simplified mastigophorene analogs on mesencephalic dopaminergic cells in primary culture (2000) (3)
- Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease (2014) (3)
- [MELAS syndrome. Clinical aspects, MRI, biochemistry and molecular genetics]. (1994) (3)
- Video-Oculography-Assisted Head Impulse Test and Caloric Testing for Detecting Stroke in Acute Vertigo Patients via Modified HINTS Plus (2021) (3)
- [Parkinson disease--a mitochondrial myopathy?]. (1993) (3)
- Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients (2016) (3)
- Normothermia after decompressive surgery for space-occupying middle cerebral artery infarction: a protocol-based approach (2017) (3)
- Delayed Comprehensive Stroke Unit Care Attributable to the Evolution of Infection Protection Measures across Two Consecutive Waves of the COVID-19 Pandemic (2021) (3)
- Efficacy and tolerability of rasagiline in daily clinical use—A post marketing observational study in patients with Parkinson’s disease focusing on non-motor symptoms and QoL (2015) (3)
- Seronegative myasthenic crisis: a multicenter analysis (2022) (3)
- Depression and anhedonia in Parkinson's disease (2002) (3)
- Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis (2022) (3)
- Quantitative succinate dehydrogenase analysis in normal and ragged-red muscle fibers (2004) (2)
- Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study (2020) (2)
- [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. (2010) (2)
- The relevance of imaging for the diagnosis of Parkinson's disease (2014) (2)
- Clinical Validation of Quality Improvements Using the Six Sigma Concept: A Case Study for Deep Brain Stimulation in Parkinson’s Disease (2019) (2)
- Modified „Bonn Protocol“ without intraventricular chemotherapy in the treatment of primary CNS lymphoma: preliminary results (2006) (2)
- [Mitochondrial encephalomyopathies. A comparison of Kearns-Sayre syndrome, MELAS and MERRF]. (1990) (2)
- The use of monoclonal antibodies in diagnostic tests for Becker and Duchenne muscular dystrophy (2004) (2)
- [Is chronic dermato- or polymyositis misdiagnosed as "weakness of old age"?]. (2008) (2)
- Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not (2022) (2)
- Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. (2022) (2)
- Botulinum toxin in the management of paradoxical activity of jaw muscles. (1995) (2)
- Mitochondrial gene mutations and diabetes mellitus. (1993) (2)
- [Molecular diagnosis of hereditary neurologic diseases. Position paper]. (2000) (2)
- Modern Therapy Management for the Improvement of the Therapy with Interferon β-1b with MSDS 3D (2012) (2)
- Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson's Disease (2022) (2)
- Spinocerebellar ataxia type 7: frequency of CAG repeat length in a German family (1999) (2)
- Palatal Tremor with Progressive Ataxia Secondary to A Dural Arteriovenous Fistula (2019) (2)
- 2.262 Adherence to antiparkinson medication in a multi-centre European study. (2007) (2)
- Parkinson's Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options - A Practise Guide. (2015) (2)
- Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson’s Disease Patients with Motor Fluctuations (2022) (2)
- Sertraline for Functional Recovery After Acute Ischemic Stroke: A Prospective Observational Study (2021) (2)
- Chapter 2 Causes of Parkinson's disease: genetics, environment and pathogenesis (2010) (2)
- PRODEST study: depressive symptoms in Parkinson's disease (2007) (2)
- Duchenne muscular dystrophy: evidence for somatic reversion of the mutation in man (1990) (2)
- Autotitrating Bilevel Positive Airway Pressure in Large Vessel Steno-Occlusive Stroke Patients With Suspected Sleep Apnea: A Multicenter Randomized Controlled Study (2021) (2)
- Disturbances of cerebrospinal fluid (CSF) circulation—neuropsychiatrie symptoms and neuroradiological contribution (2005) (1)
- 3.1-kb deletion of mitochondrial DNA in a patient with Kearns-Sayre syndrome (2004) (1)
- Deleterious Effects of Highly Halogenated ß -Carbolines on Dopaminergic Cells in Culture and on Mitochondrial Respiration (2000) (1)
- Idiopathic Parkinson's syndrome. Preface. (2011) (1)
- Impaired degradation of phytanic acid in cells from patients with mitochondriopathies: Evidence for the involvement of ETF and the respiratory chain in phytanic acid α-oxidation (1994) (1)
- Prodest - Depressive symptoms in Parkinson's disease: Demographic data (2007) (1)
- Interspecies differences in aerobic-oxidative capacities of muscle fibre populations in various mammals. (1985) (1)
- Olfaction in Parkinson’s Disease – A Clinical Approach (2020) (1)
- The Genetic Basis of Myoadenylate Deaminase Deficiency is Heterogeneous (1998) (1)
- [Executive task performance under deep brain stimulation of the subthalamic nucleus in Parkinson's disease revisited: the modulating influence of apathy, depression and mood]. (2014) (1)
- Chemical Modification of the Mitochondrial Complex I Inhibitor 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline: Synthesis and Evaluation of N-Alkanoyl Derivatives (2000) (1)
- [Muscle dystrophies]. (2004) (1)
- Measuring the Usability of eHealth Solutions for Patients With Parkinson Disease: Observational Study (2022) (1)
- Time for a new definition of Parkinson’s disease (2019) (1)
- Onset of drug-related adverse events in Parkinson's disease patients treated with opicapone in clinical practice: OPTIPARK post-hoc analysis (2020) (1)
- Phase II Trial of the Bonn Polychemotherapy Protocol with Deferred Radiotherapy in Patients with Primary Central Nervous System Lymphoma. (2006) (1)
- Nocturnal manifestations of Parkinson’s disease and atypical Parkinsonism (2014) (1)
- Abstract TMP32: Ultrasonography Grading of Internal Carotid Artery Disease: Multi-Parametric DEGUM versus SRU Consensus Criteria (2017) (1)
- Letters to the editor (1991) (1)
- Long-term survivors of a systemic and intraventricular chemotherapy with deferred radiotherapy in primary central nervous system lymphoma (2008) (1)
- [1st long-term double-blind study of effectiveness and dyskinesia prevention of ropinirol]. (2000) (1)
- NEW DEVELOPMENTS FOR PARKINSON ’ S THERAPY WITH COMT INHIBITORS This symposium took place on 22 nd September 2016 as a part of the 89 th Deutsche Gesellschaft für Neurologie ( DGN ) Congress in Mannheim , Germany (2018) (1)
- Parkinson’s disease – Many diseases with many faces (2008) (1)
- Immunochemical quantification of sarcoplasmic reticulum Ca2+-ATPase and calsequestrin in muscle biopsies from patients with myotonia congenita and paramyotonia congenita Eulenburg (2005) (1)
- Putaminal dopamine turnover predicts levodopa-induced motor complications in de novo Parkinson’s disease (S40.004) (2015) (1)
- Parkinson’s disease: a multi-faceted disease (2011) (1)
- [Entacapone for treatment of motor fluctuations in idiopathic Parkinson syndrome]. (2002) (1)
- EFFECTS OF ELECTRICAL STIMULATION UPON PARVALBUMINS IN RABBIT SKELETAL MUSCLE (1983) (1)
- [Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language]. (2020) (1)
- Efficacy of opicapone in Parkinson’s disease patients according to baseline presence of dyskinesia: A post-hoc analysis from combined BIPARK-I and II (2019) (1)
- [New prospects for therapy in Parkinson's disease]. (2013) (1)
- [Future standards in diagnosing Parkinson syndrome]. (2010) (1)
- [Diagnosis and treatment of Parkinson's disease]. (2017) (1)
- Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma (2012) (1)
- [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]. (2008) (1)
- Charcot Foot (1999) (1)
- Preface (2011) (1)
- Chapter 12 – Dopaminergic Neurotransmission (2012) (1)
- Ultrasonography Grading of Internal Carotid Artery Disease: Multiparametric German Society of Ultrasound in Medicine (DEGUM) versus Society of Radiologists in Ultrasound (SRU) Consensus Criteria (2021) (1)
- [Diagnosis and therapy of idiopathic Parkinson's disease]. (2006) (1)
- Familial myopathy with elevated serum angiotensin-converting enzyme, creatine kinase and lactate dehydrogenase isoenzyme 5 (1991) (1)
- Medical evaluation as gold standard to control iPrognosis application derived data for early Parkinson's disease detection (2020) (1)
- Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease (2022) (1)
- The Impact of Parkinson ’ s Disease on Quality of Life from Three Perspectives The Research Perspective (2014) (1)
- Inadvertent hypothermia after endovascular therapy is not associated with improved outcome in stroke due to anterior circulation large vessel occlusion (2021) (1)
- Preface to special issue on Mental Dysfunction in Parkinson's Disease (2010) (1)
- Olfaction in Parkinson’s disease (2009) (0)
- Pathobiochemical Aspects of Parkinson’s Disease and Dementia of Alzheimer Type (1990) (0)
- 8th Experts Meeting Parkinson's Disease (2007) (0)
- Safinamide – a monoamine oxidase-B inhibitor and a glutamate modulator (2020) (0)
- P1.18 Frequent nocturnal blood pressure dysregulation in various extrapyramidal syndromes (2009) (0)
- Are further national Expert Meetings called for today (2014) (0)
- Shake Hands with the Mother - Diagnosing a Floppy Infant: Myotonic Dystrophy and the Congenital Subtype (2007) (0)
- Preliminary results of a Phase II study: combined systemic polychemotherapy and intrathecal treatment with liposomal cytarabine in patients with primary CNS lymphoma ≥60 years (2009) (0)
- Abstract WP344: Vascular Unloading Technique for Continuous Non-invasive Blood Pressure Monitoring After Intravenous Thrombolysis in Acute Ischemic Stroke: Interim Analysis of a Prospective Method Comparison Study (2016) (0)
- Neurofibromatous neuropathy. (1991) (0)
- Clinical and genetic characteristics of chronic progressive external ophthalmoplegia (CPEO) (2013) (0)
- Contents Vol. 51, 2004 (2004) (0)
- Accumulationandtherapeuticmodulation of 6-sulfo LacNAc 1 dendritic cells in multiple sclerosis (2014) (0)
- Highlights of the issue 7, 2020 (2020) (0)
- [Caffeine, Chocolate and Adenosine A2A Receptor Antagonists in the Treatment of Parkinson's Disease]. (2022) (0)
- [Significance of dystrophin analysis in adult myopathies. Study methods, case reports and current pathogenetic considerations]. (1991) (0)
- [Acute atraumatic rhabdomyolysis]. (1992) (0)
- Is the Point Mutation in Codon 331 of the Mitochondrial ND2 Gene Associated with Alzheimer’s Disease? (1995) (0)
- the first three years after diagnosis Neurological disability , psychological distress , and health-related quality of life in MS patients within (2009) (0)
- Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease (2017) (0)
- Abstract WMP112: Safety and Efficacy of Intravenous Thrombolysis and Endovascular Therapy in Children with Acute Ischemic Stroke: A Systematic Review and Meta-analysis (2017) (0)
- P134 Olfactory testing in differential diagnosis of tremor (2011) (0)
- The unique nested gene ALZAS as a potential source of Aβ-peptides in Alzheimer’s disease (2018) (0)
- [Mitochondrial myopathies]. (1988) (0)
- Opicapone: From Preclinical Data to Real-world Evidence (2021) (0)
- I.6 Anhedonia and depression in Parkinson's Disease (2006) (0)
- [Standardized aerobic walking on the treadmill by healthy probands and patients with mitochondrial and non-mitochondrial myopathies]. (1997) (0)
- Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
- The use of wearables for the diagnosis and treatment of Parkinson’s disease (2023) (0)
- ACETYLCHOLINE AND CHOLINE IN LUMBAR CSF ‐ SPECIFICITY OF MEASUREMENT AND VALUES IN DEMENTIA OF ALZHEIMER TYPE (1992) (0)
- P2.103 Antidyskinetic effects of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2009) (0)
- New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies (2016) (0)
- Erratum to: Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease (2015) (0)
- Thrombolysis in the Very Elderly: Application to Telestroke Networks (P4.316) (2015) (0)
- P118 Health-related quality of life and disease-related costs in multiple system atrophy and progressive supranuclear palsy (2011) (0)
- Hope and Distress Are Not Associated With the Brain Tumor Stage (2021) (0)
- Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept (NSC) (2010) (0)
- Opicapone in clinical practice in Parkinson's disease German patients with motor fluctuations: Findings from the OPTIPARK study (2021) (0)
- Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma (2008) (0)
- Influence of disease duration on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study (2021) (0)
- Communications of the European Neurological Society (2013) (0)
- Parvalbumin reduction in relation to possible perturbations of Ca2+-homeostasis in muscular dystrophy. (1985) (0)
- 2.249A Efficacy and safety of transdermal lisuride (LIS) in advanced Parkinson's disease (PD) (2007) (0)
- Pramipexole in the management of Parkinson's disease (2008) (0)
- Opicapone in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study (2021) (0)
- Organotypic Striatal Slices: Neuroprotective Effects of Vitamins (2000) (0)
- Levodopa-Related ‘ Wearing Off ’ in Parkinson ’ s Disease : Current Therapeutic Options Professor (2017) (0)
- Disturbances of the Autonomic Nervous System in PD Patients (2005) (0)
- [Elektrophysiological methods as diagnostic tools in pain therapy]. (2008) (0)
- Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment. (2007) (0)
- Initial radiographic response predicts favorable outcome to chemotherapy in primary CNS lymphoma (2007) (0)
- Bevacizumab-induced changes in small arterial dilatation measured in vivo by dynamic retinal vessel analysis. (2010) (0)
- [New approaches to transplantation of dopamine-producing cells and stem cells]. (2003) (0)
- Abstract TP214: Low Diagnostic Yield of Routine Cerebrospinal Fluid Analysis in Patients with Juvenile Stroke (2017) (0)
- Depressive symptoms and changes in regional cerebral glucose metabolism in patients with MSA and PSP (2005) (0)
- Anti-NMDA-receptor encephalitis as cause of refractory epilepsy – report of two cases (2010) (0)
- Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of monoamine-oxidase-b inhibitors and dopamine agonists: The real-world OPTIPARK study (2021) (0)
- Safinamide as a Valuable Add-on Therapy – Exploring New Approaches to Parkinson’s Disease Management Through Patient Case Presentations (2017) (0)
- [Perioperative Management of PD Patients]. (2016) (0)
- Cellular pathophysiology and basal ganglia dysfunction in Parkinson's disease: an overview (2020) (0)
- Abstract TP162: Case Manager Guided Organized Post-stroke Care Aids in Achieving Risk Factor Goals (2016) (0)
- Influence of levodopa daily dose on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study (2021) (0)
- G.P.190 Multiple deletions in mitochondrial DNA in myofibrillar myopathy and centronuclear myopathy (2014) (0)
- P116 TAUROS: A clinical trial on Progressive Supranuclear Palsy with the GSK-3 inhibitor Tideglusib (Zentylor®) (2011) (0)
- Abstract W P379: Pre-treatment with Selective Serotonin Reuptake Inhibitors is Associated with Improved Short-term Outcome in Acute Ischemic Stroke (2015) (0)
- Mitochondrial dysfunction with MERRF point-mutation in nerve and mucle tissue of a patient with multiple symmetric lipomatosis (1997) (0)
- Abstract W P213: ,,Door-to-needle-,, Or ,,Onset-to-treatment-time”? What Is The Key Marker To Assess Telestroke Care? (2015) (0)
- Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of dopamine agonists: Findings from the real-world OPTIPARK study (2021) (0)
- P2.085 Piribedil stimulates dopaminergic neurons via dopamine receptor activation and PI3-kinase signalling and protects against MPP+ toxicity (2009) (0)
- Stroke-like episodes in familial mitochondrial encephalomyopathy: clinical and biochemical aspects (1991) (0)
- O.087 Treatment of dementia and depression in Parkinson's disease (2009) (0)
- Ophthalmoplegia plus: clinical relevance of magnetic resonance tomogaphy findings. (1997) (0)
- Parkinson’s disease—an everlasting challenge (2004) (0)
- New Frontiers in Parkinson's Disease (2002) (0)
- Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals (2023) (0)
- The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies (2023) (0)
- Value of Differenf Markers in Cerebrospinal Fluid for Diagnostics of Creutzfeldt-Jakob Disease: Evaluation in Three Cases (1999) (0)
- Clinical data on the prolonged-release formulation of ropinirole for Parkinson’s disease (2011) (0)
- Chronic recurrent meningitis with intrathecal igg synthesis (1989) (0)
- Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations: findings from the OPTIPARK study (2020) (0)
- Polymorphism of the prion protein gene in German patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy (2004) (0)
- Underlying biochemical and molecular mechanisms of dyskinesia (2005) (0)
- [Therapeutic chances in neurology]. (2015) (0)
- Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease (2017) (0)
- Title Progression of Parkinson ’ s disease pathology is reproduced by intragastric administration of rotenone in mice Authors and Affiliations (2010) (0)
- [Hallucinations in Patients with Idiopathic Parkinson's Disease]. (2021) (0)
- Transplantation of PSA‐NCAM expressing embryonic stem cell‐derived neural progenitors in organotypic mouse gut cultures (2007) (0)
- 1.167 PRODEST – Depressive symptoms in Parkinson's disease: Pattern across scales (2007) (0)
- [Optimization of long-term care of neurological patients through internet- and mobile-based interventions with and without persuasive elements including gamification]. (2020) (0)
- Long-term survivors of a systemic and intraventricular chemotherapy with deferred radiotherapy in primary central nervous system lymphoma (PCNSL) (2008) (0)
- Development and Validation of a Fall Questionnaire for Patients with Parkinson's Disease (2022) (0)
- Rational Therapy of Idiopathic Parkinson's Disease with Dopamine Agonists (2007) (0)
- [The mitochondrial genome and its deletions as a cause of disease]. (1990) (0)
- Primary C entral N ervous S ystem L ymphoma: R esults o f a P ilot and P hase I I S tudy o f S ystemic a nd I ntraventricular Chemotherapy W ith D eferred R adiotherapy (2003) (0)
- MITOCHONDRIAL GENE MUTATIONS AND DIABETES MELLITUS: AUTHORS' REPLY (1993) (0)
- Das mitochondriale Genom (1996) (0)
- Abstract W P136: SOS CARE: The Stroke East Saxony Pilot Project for Integrated Care Pathway and Case Management After Stroke (2014) (0)
- Influence of demographic characteristics on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study (2021) (0)
- LB016-SUN TELEDYSPHAGIA FOR ACUTE STROKE PATIENTS USING A STANDARDIZED EXAMINATION KIT IN A TELESTROKE NETWORK (2013) (0)
- The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence (2020) (0)
- Telemedicine tailored to patient's needs: Assessing usability and user experience in patients with Parkinson's disease (2020) (0)
- Effects of Multiple Sclerosis Therapies on the Gut Immune System (P6.191) (2016) (0)
- Mitochondrial Disturbances in Parkinson’s Disease (1994) (0)
- [Complexity of Parkinson Syndrome]. (2016) (0)
- Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage (“Neuroprotection”) (2015) (0)
- [The future of the Parkinson syndrome]. (2010) (0)
- Biochemical studies inmitochondrial encephalomyopathy (1987) (0)
- Monday, 10 December 200717.00–18.30Afternoon Industry Satellite SymposiumRoom B1.IS.4.3 Efficacy and safety of transdermal lisuride (LIS) in advanced Parkinson's disease (PD) (2007) (0)
- JNT Special Issue MDPD Congress, Berlin 2012 (2013) (0)
- Medical follow up assessments of iPrognosis application users for early Parkinson's disease detection (2020) (0)
- P3.063 The unique properties of 9-methyl-b-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects (2009) (0)
- 13. Experten Meeting Parkinson (2007) (0)
- P 36 Structural and functional imaging findings in somatoparaphrenia (2017) (0)
- Seventeenth Meeting of the European Neurological Society 16–20 June 2007, Rhodes, Greece (2007) (0)
- The dopaminergic system: an everlasting challenge. Editorial. (2006) (0)
- Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: Findings from the OPTIPARK study (2021) (0)
- [Practical experience on improving activities of daily living competence in Parkinson's patients treated with ropinirole. Results of a applied study]. (2005) (0)
- Neurocognitive Plasticity in Frontotemporal Aplasia: A Case Report (2014) (0)
- Parkinson’s disease—an everlasting challenge (2004) (0)
- 4096Cardiac manifestation in wilson disease. The CARMA Wilson study. A comprehensive clinical and cardiac imaging trial (2017) (0)
- Abstract WP130: Validation of Multi-parametric Ultrasonography Criteria with Catheter Angiography in Internal Carotid Artery Disease: A Prospective Multicenter Study (2016) (0)
- [Welcome to the DGN Congress]. (2017) (0)
- Die German Study on the Epidemiology of Parkinson's Disease with Dementia (GEPAD): mehr als nur Parkinson (2010) (0)
- [Early detection of Parkinson syndrome]. (2002) (0)
- 2.002 PD: Autonomic dysfunction (2007) (0)
- Influence of onset of motor fluctuations on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study (2021) (0)
- Influence of demographic characteristics in the efficacy response of Parkinson’s disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II (2019) (0)
- [Mitochondrial diseases]. (2001) (0)
- Professor Kenneth Ricker (1935–2004) (2004) (0)
- Abstract WP2: Videooculography-assisted Head Impulse Test And Caloric Testing Improve Clinical Algorithms For Detecting Stroke In Acute Vertigo Patients (2022) (0)
- COMT-Inhibition for Treatment of Wearing-off (2005) (0)
- Polychemotherapy in patients with primary CNS lymphoma. (2004) (0)
- 2.8.3 THE VALUE OF DELAYING CLINICAL PROGRESSION OF PARKINSON'S DISEASE FROM A CLINICIAN, PATIENT, AND SOCIETAL PERSPECTIVE (2012) (0)
- Sleep in patients with Parkinson's disease: Differences in two groups of 219 patients with and without sleep disturbances (2017) (0)
- Future Therapy in Idiopathic Parkinson's Disease (2003) (0)
- ENS Communications (2010) (0)
- Subject Index Vol. 51, 2004 (2004) (0)
- [Pushing back frontiers in neurology]. (2014) (0)
- [20th Experten Meeting Parkinson]. (2020) (0)
- Strukturierte Diagnostik bei Parkinson-Syndromen (2005) (0)
- Correction to: 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes (2021) (0)
- [The early therapy challenge]. (2005) (0)
- Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: Findings from the real-world OPTIPARK study (2021) (0)
- Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: Findings from the real-world OPTIPARK study (2021) (0)
- [Epilepsy: recommendations for daily activities]. (2011) (0)
- German Society of Neurology - Successful In Spite of Stormy Waters (2009) (0)
- Abstracts – Fifth Congress Deutsche Parkinson-Gesellschaft e.V. (2006) (0)
- [Sensory and autonomic small fiber neuropathy]. (2015) (0)
- Hypothesis of Ascension in Idiopathic Parkinson’s Disease (2017) (0)
- Primary Skin Fibroblasts as a Model of Parkinson's Disease (2012) (0)
- methoxytyramine spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass (2013) (0)
- Morbidity Milestones Demonstrate Long Disability‐Free Survival in Parkinson's Disease Patients with Deep Brain Stimulation of the Subthalamic Nucleus (2023) (0)
- Abstract T P383: The Stroke East Saxony Pilot Project For Organized Post-Stroke Care: A Case-Control Study (2015) (0)
- Advanced Parkinson's Disease Patients Eat Less Food in Comparison to Early Parkinson's Patients and Healthy Controls in a Controlled Lunch Setting (2020) (0)
- Parkinson’s disease and translational research (2020) (0)
- Enzymatic Analyses of Beta-Oxidation in Human Fibroblasts from Patients with Reye’s Syndrome (1987) (0)
- [Medicine on the move]. (2013) (0)
- Relapse of Central Nervous System Lymphoma after systemic Lymphoma (SCNSL): Clinical Features and Outcome as compared to Primary CNS Lymphoma (PCNSL) Patients (2008) (0)
- P1.100 Effects of dopaminergic treatment on putaminal dopamine turnover measured with (2009) (0)
- Influence of Dietary Constituents on Motor and Non-motor Symptoms in Parkinson’s Disease (2015) (0)
- Physiological and pathological changes in the enteric nervous system of rotenone-exposed mice as early biomarkers for Parkinson’s disease (2020) (0)
- Morbidity milestones demonstrate long disability‐free survival in PD patients with STN‐DBS (2023) (0)
- Mitochondrial encephalopathies: Neurophysiological, biochemical and molecular genetic approach (1997) (0)
- The genetic basis of myoadenylate deaminase deficiency is heterogeneous. (1997) (0)
- [Muscular atrophy as a symptom]. (2004) (0)
- 2.216 Rasagiline in daily clinical use – a post-marketing observational study in Parkinsonian patients receiving combination therapy shows good efficacy and tolerability (2007) (0)
- Influence of baseline off-time in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II (2019) (0)
- OLFACTORY DYSFUNCTION IN EARLY PD SUGGESTS THAT THE DISEASE IS CAUSED BY A TOXIN (2007) (0)
- 2.249 EFFICACY OF RASAGILINE IN COMBINATION WITH DOPAMINE AGONIST THERAPY: RESULTS FROM A POST-MARKETING OBSERVATIONAL STUDY IN PATIENTS WITH PARKINSON'S DISEASE (2012) (0)
- 5-29-10 Mitochondrial dysfunction with MERRF point-mutation in nerve and muscle tissue of a patient with multiple symmetric lipomatosis (1997) (0)
- [Microsurgical reconstruction of the accessory nerve]. (1990) (0)
- [Medication treatment for Parkinson's disease]. (2005) (0)
- Abstract P598: Increased Risk of Acute Stroke in Patients With Severe Course of Covid-19: A Multicenter Study and Meta-Analysis (2021) (0)
- Genome-wide expression profiling of A3243G MELAS patients in quest for potential disease-modifying target genes (2007) (0)
- A 400-kb tandem duplication within the dystrophin gene leads to severe Becker muscular dystrophy (1994) (0)
- Contents Vol. 8, 2011 (2011) (0)
- Do colour discrimination and contrast sensitivity help to distinguish Parkinson's disease, multiple system atrophy and progressive supranuclear palsy? (2004) (0)
- Studie zur Evaluation der diagnostischen Wertigkeit der Nervensonografie in der Diagnostik peripherer Polyneuropathien (2013) (0)
- Reversible bilaterale Thalamitis (1989) (0)
- P1.19 Semi-quantitative questionnaire of autonomic symptoms in patients with extrapyramidal syndromes in relation to autonomic testing (2009) (0)
- Electron Transport Chain Defects in Alzheimer's Disease (1995) (0)
- [Mitochondrial myopathy]. (1992) (0)
- Caffeine, chocolate, and adenosine antagonism in Parkinson’s disease (2022) (0)
- Premotor Diagnosis of Parkinson’s Disease (2017) (0)
- Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology (2014) (0)
- Perioperatives Management der Parkinsonkrankheit in Deutschland (2007) (0)
- NEUROTOXICITY AND NEUROPROTECT1ON (1996) (0)
- Abstract TP14: Duration of Anesthesia Negatively Affects Functional Outcome After Endovascular Therapy for Acute Ischemic Stroke (2018) (0)
- Opicapone analysis of health economic costs in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Heinz R. Reichmann?
Heinz R. Reichmann is affiliated with the following schools:
